The Efficacy of Botulinum Toxin in OVERACTIVE Bladder
NCT03888001 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2019-03-25
Summary
To assess the efficacy of botulinum toxin injection in overactive bladder.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
AHMED FARAHAT, MASTER · Assiut University
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2019-04-01
- Completion
- 2020-03-01
Countries
- Egypt
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)
NCT02786407 ·Status: UNKNOWN ·Phase: PHASE3
-
BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence
NCT03320850 ·Status: COMPLETED ·Phase: PHASE2
-
Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia
NCT03385161 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
NCT00461292 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial
NCT07184307 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
NCT00578097 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
NCT00439140 ·Status: TERMINATED ·Phase: PHASE3
-
BOTOX® at the Time of Prolapse Surgery for OAB
NCT04807920 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
NCT00311376 ·Status: COMPLETED ·Phase: PHASE3
-
Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility Study
NCT03385460 ·Status: UNKNOWN ·Phase: NA
-
Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder
NCT02673047 ·Status: COMPLETED
-
Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
NCT00910520 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India
NCT02590250 ·Status: COMPLETED
-
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.
NCT00231491 ·Status: COMPLETED ·Phase: PHASE2
-
Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?
NCT04124939 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder
NCT02995967 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
NCT00575016 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity
NCT05968885 ·Status: RECRUITING ·Phase: PHASE4
-
Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
NCT00915525 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease
NCT05997043 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
NCT01767519 ·Status: COMPLETED ·Phase: PHASE3
-
Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome
NCT01657409 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis
NCT00876447 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients
NCT03063827 ·Status: COMPLETED
-
Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
NCT00910845 ·Status: COMPLETED ·Phase: PHASE3